Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The small intestinal epithelium is a specialized tissue layer that serves as the primary interface between the external environment and the internal systemic circulation. It is responsible for the digestion and absorption of nutrients, electrolytes, and water while simultaneously acting as a selective barrier against luminal pathogens and toxins (StatPearls, 2023). This complex layer is composed of various cell types, including absorptive enterocytes, mucus-secreting goblet cells, and hormone-producing enteroendocrine cells, all of which are essential for metabolic homeostasis (NIH, 2022). In conditions such as Celiac disease or inflammatory bowel disease, the structural integrity of the epithelium is compromised, leading to chronic inflammation and nutrient deficiencies (PubMed, 2021). While the epithelium itself is an anatomical structure rather than a single molecular target, it expresses numerous specific receptors and transporters, such as the GLP-2 receptor targeted by Teduglutide to treat short bowel syndrome (Nature Reviews Gastroenterology & Hepatology, 2020). Consequently, therapeutic interventions often focus on preserving this barrier or modulating the specific molecular pathways contained within its constituent cells (PubChem, 2023).
Drugs interacting with the small intestinal epithelium typically function by activating specific G protein-coupled receptors to promote mucosal growth, modulating apical ion channels to alter fluid secretion, or providing local anti-inflammatory effects to maintain barrier integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small intestinal epithelium.